Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA018142 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA018142, RRID:AB_1856757
- Product name
- Anti-SETDB1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SETDB1, Gene description: SET domain, bifurcated 1, Alternative Gene Names: ESET, KG1T, KIAA0067, KMT1E, TDRD21, Validated applications: IHC, ICC, Uniprot ID: Q15047, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Cytoplasmic localization of SETDB1‑induced Warburg effect via c‑MYC‑LDHA axis enhances migration and invasion in breast carcinoma
RETRACTED ARTICLE: SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway
A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer
Smad3‐mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial–mesenchymal transition
SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Yang W, Wei Y, Wang T, Xu Y, Jin X, Qian H, Yang S, He S
International Journal of Molecular Medicine 2024;53(4)
International Journal of Molecular Medicine 2024;53(4)
RETRACTED ARTICLE: SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway
Han S, Zhen W, Guo T, Zou J, Li F
Journal of Experimental & Clinical Cancer Research 2020;39(1)
Journal of Experimental & Clinical Cancer Research 2020;39(1)
A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer
Chen B, Wang J, Wang J, Wang H, Gu X, Tang L, Feng X
Bioscience Reports 2018;38(5)
Bioscience Reports 2018;38(5)
Smad3‐mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial–mesenchymal transition
Du D, Katsuno Y, Meyer D, Budi E, Chen S, Koeppen H, Wang H, Akhurst R, Derynck R
EMBO reports 2017;19(1):135-155
EMBO reports 2017;19(1):135-155
SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway
Sun Q, Ding L, Xiao J, Chien W, Lim S, Hattori N, Goodglick L, Chia D, Mah V, Alavi M, Kim S, Doan N, Said J, Loh X, Xu L, Liu L, Yang H, Hayano T, Shi S, Xie D, Lin D, Koeffler H
The Journal of Pathology 2015;235(4):559-570
The Journal of Pathology 2015;235(4):559-570
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
Rodriguez-Paredes M, Martinez de Paz A, Simó-Riudalbas L, Sayols S, Moutinho C, Moran S, Villanueva A, Vázquez-Cedeira M, Lazo P, Carneiro F, Moura C, Vieira J, Teixeira M, Esteller M
Oncogene 2013;33(21):2807-2813
Oncogene 2013;33(21):2807-2813
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Ceol C, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando D, Battisti V, Fritsch L, Lin W, Hollmann T, Ferré F, Bourque C, Burke C, Turner L, Uong A, Johnson L, Beroukhim R, Mermel C, Loda M, Ait-Si-Ali S, Garraway L, Young R, Zon L
Nature 2011;471(7339):513-517
Nature 2011;471(7339):513-517
No comments: Submit comment
No validations: Submit validation data